NCT05740475 2025-12-09
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1 Completed
Mabwell (Shanghai) Bioscience Co., Ltd.
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
St. James's Hospital, Ireland